{
  "denotations": [
    {
      "id": "T1",
      "obj": "Disease",
      "span": {
        "begin": 22,
        "end": 35
      }
    },
    {
      "id": "T2",
      "obj": "Chemical",
      "span": {
        "begin": 52,
        "end": 55
      }
    },
    {
      "id": "T4",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 121,
        "end": 127
      }
    },
    {
      "id": "T5",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 142,
        "end": 148
      }
    },
    {
      "id": "T7",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 156,
        "end": 162
      }
    },
    {
      "id": "T9",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 181,
        "end": 184
      }
    }
  ],
  "sourcedb": "PubMed",
  "sourceid": "18628428_8",
  "text": "The increased risk of breast cancer associated with E+P use was greater among women with at least one rare allele of the CYP1A1 Ile(462)Val , CYP1A1 MspI , CYP1B1 Asn(453)Ser , and PGR Val(660)Leu polymorphisms than among women homozygous for the common allele of these polymorphisms ."
}
